Catalog No.
DHJ92704
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Humanized
Isotype
IgG1-kappa
Clonality
Monoclonal
Target
Ig epsilon chain C region, IGHE, Ig epsilon chain C region ND, Immunoglobulin heavy constant epsilon
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P01854
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
47H4, Anti-M1 prime, MEMP1972A, RG-7449, CAS: 1228538-47-3
Clone ID
Quilizumab
A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma, PMID: 26993628
A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria, PMID: 27567329
An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases, PMID: 29290750
Anti-IgE for the Treatment of Chronic Urticaria, PMID: 33628747
Emerging Biomarkers and Therapeutic Pipelines for Chronic Spontaneous Urticaria, PMID: 30033912
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production, PMID: 24990880
The use of biologics in food allergy, PMID: 33966304
Biologics to treat anaphylaxis., PMID:37527059
Mapping knowledge structure and research of the biologic treatment of asthma: A bibliometric study., PMID:36845128
The use of biologics in food allergy., PMID:33966304
Anti-IgE for the Treatment of Chronic Urticaria., PMID:33628747
Emerging Biomarkers and Therapeutic Pipelines for Chronic Spontaneous Urticaria., PMID:30033912
An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases., PMID:29290750
A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria., PMID:27567329
A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma., PMID:26993628
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production., PMID:24990880
For research use only. Not for human or drug use.
